Literature DB >> 2662828

Plasma-derived and yeast-derived hepatitis B vaccines.

R W Ellis1, R J Gerety.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2662828     DOI： 10.1016/0196-6553(89)90214-9

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN： 0196-6553            Impact factor:   2.918


× No keyword cloud information.
  2 in total

Review 1.  Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development.

Authors:  Natasha Kushnir; Stephen J Streatfield; Vidadi Yusibov
Journal:  Vaccine       Date:  2012-11-06       Impact factor: 3.641

Review 2.  Hepatitis B core-based virus-like particles: A platform for vaccine development in plants.

Authors:  Maryam Moradi Vahdat; Farshad Hemmati; Abozar Ghorbani; Daria Rutkowska; Alireza Afsharifar; Mohammad Hadi Eskandari; Nahid Rezaei; Ali Niazi
Journal:  Biotechnol Rep (Amst)       Date:  2021-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.